These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17706742)

  • 21. Identification of human UGT2B7 as the major isoform involved in the O-glucuronidation of chloramphenicol.
    Chen M; LeDuc B; Kerr S; Howe D; Williams DA
    Drug Metab Dispos; 2010 Mar; 38(3):368-75. PubMed ID: 20008037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10.
    Kaivosaari S; Toivonen P; Hesse LM; Koskinen M; Court MH; Finel M
    Mol Pharmacol; 2007 Sep; 72(3):761-8. PubMed ID: 17576790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spironolactone and canrenone inhibit UGT2B7-catalyzed human liver and kidney microsomal aldosterone 18beta-glucuronidation: a potential drug interaction.
    Knights KM; Bowalgaha K; Miners JO
    Drug Metab Dispos; 2010 Jul; 38(7):1011-4. PubMed ID: 20304966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective glucuronidation of propranolol in human and cynomolgus monkey liver microsomes: role of human hepatic UDP-glucuronosyltransferase isoforms, UGT1A9, UGT2B4 and UGT2B7.
    Hanioka N; Hayashi K; Shimizudani T; Nagaoka K; Koeda A; Naito S; Narimatsu S
    Pharmacology; 2008; 82(4):293-303. PubMed ID: 18936551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
    Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
    Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.
    Miners JO; Mackenzie PI; Knights KM
    Drug Metab Rev; 2010 Feb; 42(1):196-208. PubMed ID: 19795925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strong inhibitory effect of medroxyprogesterone acetate (MPA) on UDP-glucuronosyltransferase (UGT) 2B7 might induce drug-drug interactions.
    Huang T; Fang ZZ; Yang L
    Pharmazie; 2010 Dec; 65(12):919-21. PubMed ID: 21284263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen.
    Wang H; Yuan L; Zeng S
    Biochem Pharmacol; 2011 Dec; 82(11):1757-63. PubMed ID: 21856293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photoaffinity labeling of the aglycon binding site of the recombinant human liver UDP-glucuronosyltransferase UGT1A6 with 7-azido-4-methylcoumarin.
    Senay C; Battaglia E; Chen G; Breton R; Fournel-Gigleux S; Magdalou J; Radominska-Pandya A
    Arch Biochem Biophys; 1999 Aug; 368(1):75-84. PubMed ID: 10415114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes.
    Kaivosaari S; Toivonen P; Aitio O; Sipilä J; Koskinen M; Salonen JS; Finel M
    Drug Metab Dispos; 2008 Aug; 36(8):1529-37. PubMed ID: 18474681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation into UDP-glucuronosyltransferase (UGT) enzyme kinetics of imidazole- and triazole-containing antifungal drugs in human liver microsomes and recombinant UGT enzymes.
    Bourcier K; Hyland R; Kempshall S; Jones R; Maximilien J; Irvine N; Jones B
    Drug Metab Dispos; 2010 Jun; 38(6):923-9. PubMed ID: 20304965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homodimerization of UDP-glucuronosyltransferase 2B7 (UGT2B7) and identification of a putative dimerization domain by protein homology modeling.
    Lewis BC; Mackenzie PI; Miners JO
    Biochem Pharmacol; 2011 Dec; 82(12):2016-23. PubMed ID: 21930117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carboxyl-glucuronidation of mitiglinide by human UDP-glucuronosyltransferases.
    Yu L; Lu S; Lin Y; Zeng S
    Biochem Pharmacol; 2007 Jun; 73(11):1842-51. PubMed ID: 17359941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: implications for in vitro-in vivo extrapolation.
    Rowland A; Gaganis P; Elliot DJ; Mackenzie PI; Knights KM; Miners JO
    J Pharmacol Exp Ther; 2007 Apr; 321(1):137-47. PubMed ID: 17237258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors.
    Liu Y; She M; Wu Z; Dai R
    J Enzyme Inhib Med Chem; 2011 Jun; 26(3):386-93. PubMed ID: 20939765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases.
    Uchaipichat V; Mackenzie PI; Elliot DJ; Miners JO
    Drug Metab Dispos; 2006 Mar; 34(3):449-56. PubMed ID: 16381668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.
    Itäaho K; Mackenzie PI; Ikushiro S; Miners JO; Finel M
    Drug Metab Dispos; 2008 Nov; 36(11):2307-15. PubMed ID: 18719240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33.
    Barre L; Fournel-Gigleux S; Finel M; Netter P; Magdalou J; Ouzzine M
    FEBS J; 2007 Mar; 274(5):1256-64. PubMed ID: 17263731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.
    Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO
    Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosidation of an endothelin ET(A) receptor antagonist and diclofenac in human liver microsomes: aglycone-dependent UDP-sugar selectivity.
    Tang C; Ma B
    Drug Metab Dispos; 2005 Dec; 33(12):1796-802. PubMed ID: 16129696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.